Erkka Järvinen

10PUBLICATIONS
25CO-AUTHORS
PharmacogenomicsMedical mycologyMolecular targetsToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 03, 2026
Dicloxacillin and Flucloxacillin Inhibit Hepatic Uptake Transporters-In Vitro Investigations and Physiologically Based Pharmacokinetic Modeling.

Noora Sjöstedt, Ogochukwu U Amaeze, Jeroen J M W van den Heuvel

|Nov 24, 2025
Dicloxacillin and flucloxacillin inhibit hepatic uptake transporters -in vitro investigations and physiologically based pharmacokinetic modelling.

Noora Sjöstedt, Ogochukwu U Amaeze, Jeroen Jmw van den Heuvel

|Jun 23, 2025
Limited Sampling Strategies to Predict Mycophenolic Acid and Tacrolimus Area Under the Concentration-Time Curve in Steroid-Free Kidney Transplant Patients.

Katrine Agergaard, Helle C Thiesson, Jan Carstens

|Aug 19, 2024
Dicloxacillin is an inducer of intestinal P-glycoprotein but neither dicloxacillin nor flucloxacillin increases the risk of stroke/systemic embolism in direct oral anticoagulant users.

Ditte B Iversen, Ann-Cathrine Dalgård Dunvald, Martin Thomsen Ernst

|May 26, 2023
Flucloxacillin Is a Weak Inducer of CYP3A4 in Healthy Adults and 3D Spheroid of Primary Human Hepatocytes.

Ditte B Iversen, Ann-Cathrine Dalgård Dunvald, Daniel M Jespersen

|Apr 06, 2023
Dicloxacillin-warfarin drug-drug interaction-A register-based study and in vitro investigations in 3D spheroid primary human hepatocytes.

Erkka Järvinen, Ann-Cathrine Dalgård Dunvald, Martin Thomsen Ernst

Pageof 2